➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Details for Patent: 5,900,488

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,900,488
Title: Method for treating mycosis using imidazolylacetonitrile derivatives
Abstract:R-(+)-(E)-[4-(2-Chlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolylacetonit rile, R-(-)-(E)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolylace tonitrile, and pharmaceutically acceptable salts thereof which can be used as a pharmaceutical agent are disclosed. A process for producing them and a method for treating mycoses using them are also disclosed.
Inventor(s): Kodama; Hiroki (Osaka, JP), Niwano; Yoshimi (Osaka, JP), Kanai; Kazuo (Osaka, JP), Yoshida; Masanori (Wakayama, JP)
Assignee: Nihon Nohyaku Co., Ltd. (Tokyo, JP)
Application Number:08/981,420
Patent Claim Types:
see list of patent claims
Compound; Composition; Process; Use;

Drugs Protected by US Patent 5,900,488

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,900,488

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan7-196174Jul 8, 1995
PCT Information
PCT FiledJuly 05, 1996PCT Application Number:PCT/JP96/01872
PCT Publication Date:January 30, 1997PCT Publication Number: WO97/02821

International Family Members for US Patent 5,900,488

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 407832 ⤷  Free Forever Trial
Austria A906196 ⤷  Free Forever Trial
Australia 6319296 ⤷  Free Forever Trial
Australia 697571 ⤷  Free Forever Trial
Canada 2226214 ⤷  Free Forever Trial
Switzerland 692045 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.